Association between dietary calcium to Phosphorus Ratio and the odds of ulcerative colitis: A case-control study
- PMID: 38500985
- PMCID: PMC10945169
- DOI: 10.1016/j.heliyon.2024.e27556
Association between dietary calcium to Phosphorus Ratio and the odds of ulcerative colitis: A case-control study
Abstract
Background & aims: Ulcerative colitis (UC) is a recurrent, inflammatory, autoimmune intestinal disease. The dietary calcium to phosphorus (Ca:P) ratio is suggested to affect the inividuals' normal metabolic and inflammatory pathways. The present study aimed to investigate the association between dietary Ca:P ratio and the odds of developing UC in a case-control format.
Methods: The study included sixty-two currently diagnosed UC patients and one hundred twenty-four matched controls, designed as a case-control study. The dietary intakes of the participants were assessed by a food frequency questionnaire (FFQ), and the dietary Ca:P ratio was calculated. The association between tertiles of Ca:P ratio and UC was examined using the logistic regression. P-values <0.05 were considered as significant.
Results: The study sample consisted of participants with an average age of 36.63 ± 12.42 years and a mean body mass index (BMI) of 25.39 ± 3.82 kg/m2. The overall energy-adjusted ratio of Ca:P was 0.74 ± 0.11. In the multivariate model, after adjustment for potential confounders, participants in the third tertile of dietary Ca:P ratio had a lower odds of developing UC compared to the lowest tertlie (OR: 0.34, 95% CI: 0.13-0.87; p = 0.026).
Conclusion: Our results indicate that a higher ratio of dietary Ca:P ratio might be protective against developing UC. However, further studies are warranted to examine this association in various populations.
Keywords: Dietary calcium; Dietary intake; Dietary phosphorus; Inflammatory bowel diseases; Ulcerative colitis.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Chang J.T. Pathophysiology of inflammatory bowel diseases. N. Engl. J. Med. 2020;383:2652–2664. - PubMed
-
- Friedrich M., Pohin M., Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50:992–1006. - PubMed
-
- Bernstein C.N., Fried M., Krabshuis J.H., Cohen H., Eliakim R., Fedail S., et al. World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis. 2010;16:112–124. - PubMed
-
- Peña-Sánchez J.N., Osei J.A., Marques Santos J.D., Jennings D., Andkhoie M., Brass C., et al. Increasing prevalence and stable incidence rates of inflammatory bowel disease among first nations: population-based evidence from a western Canadian province. Inflamm. Bowel Dis. 2021;28:514–522. - PMC - PubMed
-
- Malekzadeh M.M., Vahedi H., Gohari K., Mehdipour P., Sepanlou S.G., Ebrahimi Daryani N., et al. Emerging epidemic of inflammatory bowel disease in a middle income country: a nation-wide study from Iran. Arch. Iran. Med. 2016;19:2–15. - PubMed
LinkOut - more resources
Full Text Sources